Zimmer Biomet Holdings, Inc. (ZBH) announced FDA 510(k) clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System. Zimmer Biomet will conduct a targeted release of ROSA Knee with OptimiZe later in the current year with commercial availability in the U.S. expected in the first quarter of 2026.
ROSA Knee with OptimiZe personalizes the surgeon's experience with customized intelligent surgical planning and new positioning, tracking and alignment features. The technology provides a simplified user interface that allows surgeons to choose the information they want to see, when they want to see it.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.